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Editorial on the Research Topic
The Mononuclear Phagocyte System in Infectious Disease
The term “Mononuclear Phagocyte System” (MPS) was introduced by van Furth and Cohn in
1968 to describe a group of leukocytes that shared phenotypic features (e.g., a single nucleus)
and biological functions (e.g., phagocytosis) (1). This term served originally to characterize bone
marrow progenitors, blood monocytes, and tissue macrophages, under the assumption that it was
a linear progression from progenitor to monocyte, and from monocyte to macrophage. Upon
the discovery of dendritic cells (DC) in 1973 by the late Nobel Laureate, Ralph Steinman, and
subsequent inclusion of this cell type as part of MPS in the late 1970s, the term “MPS” undertook a
specialized function for processing and presenting antigen to activate lymphocytes (2). Monocytes,
DCs, and macrophages became referred to as antigen-presenting cells (APC). Today, beyond
serving as primordial APCs, these cells are also known to play roles in thermogenesis, tissue
development, and organ function, maintenance of homeostasis, microbiota interactions, innate
immunity against pathogens, inflammation and its resolution, and wound healing and tissue repair,
among others (3). Also, it is now clear that monocytes, DCs andmacrophages, are not homogenous
populations (4). Recent conceptual advances concerning the MPS ontogeny and development
have shattered the traditional view of DCs and macrophages as linear derivates and functional
variations of monocytes (5). It is predicted that the incorporation of new technologies (e.g., mass
cytometry, single-cell RNA sequencing) along with the progress in imaging capacities, will continue
to unveil cellular heterogeneity and behavior in different tissues, differentiation trajectories, and the
identification of novel immune functions, within the mouse and human MPS (5). Therefore, as the
MPS field continues its unrelenting progress, it is important to regularly revisit the MPS conceptual
framework in health and disease.
This is precisely what we accomplished through the collection of articles in this research topic
entitled “The Mononuclear Phagocyte System in Infectious Disease”. As its title indicates, there
are a total of 60 articles (26 original research and 34 literature reviews) written by 379 authors
and published within this eBook dealing with multiple aspects of host-pathogen interaction.
The tenet of this article collection is that a better understanding of MPS in infection will yield
insights for development of therapeutics to enhance antimicrobial processes or dampen detrimental
inflammation, for the benefit of the host. We believe that the contributions made to this topic will
serve as a platform for discussion and debate about relevant issues and themes in this field.
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INTRODUCTION TO MPS BIOLOGY AND
FUNCTION
For didactic purposes, we begin this collection with a series
of “introductory” articles where readers can find general
informations about MPS biology and functions in the context of
infectious and inflammatory diseases.
Addressing cell-intrinsic functions, Uribe-Querol and
Rosales discuss the influence on phagocytosis by microbial
pathogens. Following an overview of phagocytosis and the
antimicrobial factors employed by MPS, they summarize
the microbial strategies used to inhibit phagocytosis at the
level of ingestion, phagosome formation, and maturation,
including microbial escape from these vesicles. Münz takes on
autophagy in the context of viral infection. He describes recent
evidence for how autophagy proteins regulate endocytosis and
exocytosis in MPS cell activation, viral replication, and antigen
presentation. Reciprocally, Bah and Vergne focus on autophagy
in the context of bacterial infections. They discuss multiple
functions of autophagy proteins in conferring cell defense
against bacteria, and discuss how some pathogenic bacteria
manipulate autophagy. Together, these authors argue that a
better understanding of autophagy proteins might yield new
therapeutic approaches against pathogenic infections. In terms of
factors involved in the inflammatory response against pathogens,
Weber et al. cast light on Bruton’s tyrosine kinase (BTK).
Beyond its central role as a mediator of B cell receptor signaling,
BTK is crucial in the recognition of infectious agents, cellular
maturation, and recruitment, and inflammasome regulation.
Thus, it will be beneficial to improve our understanding of
BTK biology not only as a kinase, but also as a scaffold protein,
within the MPS. As a final point in cell-intrinsic properties,
Karaji and Sattentau take on the efferocytosis of pathogen-
infected cells, which is the process of clearing of unwanted
cells by MPS. After a description of pathogen-triggered cell
death and the signals inducing efferocytosis, they discuss how it
controls different pathogenic infections and generates immune
responses. Conversely, pathogens have evolved ingenious
strategies to subvert efferocytosis, thus opening avenues to block
immune evasion and pathogen persistence. The importance of
efferocytosis in the resolution of inflammation is highlighted in
the study by Lutati et al., who identified a neutrophil-derived
glycoprotein lactoferrin (Lf) that triggers resolution-phase
macrophages. Indeed, they demonstrate that Lf promotes
the conversion of pro-inflammatory into pro-resolution
macrophages that have enhanced efferocytotic capacity to clear
apoptotic neutrophils.
We continue our introductory articles to address
pathophysiological aspects of the MPS. Dorhoi and Du
Plessis take on the monocytic-like myeloid-derived suppressor
cells (M-MDSC), which inhibit innate and adaptive immune
cell activation, proliferation, viability, trafficking, and cytokine
production, to promote peripheral tolerance against unwanted
inflammation during pathogenic infection. However, M-MDSC
also serve as reservoirs for pathogens favoring their survival and
limiting optimal host responses, highlighting the need to better
understand their genesis and biological functions in chronic
infections. Silva et al. focus on the role of E-Selectin ligands
to home blood-borne MPS cells into infection sites. Insights to
the structural and functional properties of E-Selectin ligands
in MPS cells are likely to improve the efficiency of immune
responses and ameliorate immunopathology derived from
chronic inflammation. Within the context of cell migration,
Cougoule et al. reveal the importance of podosomes (actin-
rich structures found specifically on the basal membrane
of MPS cells) for the capacity of human DCs to penetrate
dense microenvironments. This study describes the influence of
pathogen-derived signals on podosome formation and dynamics,
thus dictating the mode of migration of DCs toward infectious
sites. Da Silva et al. provide an overview on Peyer’s patch MPS
in health and disease. This includes MPS cell diversity and
specificity, anatomical localization, functions, interaction with
microbiota and generation of humoral immunity, and their role
in multiple infectious contexts.
Recent advances in MPS biology in the cardiovascular system
is the subject for the review by Sanmarco et al. MPS cells
play roles in cardiac inflammation and infection, such as in
Chagas cardiomyopathy, viral myocarditis, bacterial infections,
sterile inflammation, among other disorders. The authors
highlight the importance of dissecting the signaling pathways
and molecules modulating MPS functions during infection.
Lastly, Poulin et al. tackle the myeloid postulate of immune
paralysis in sepsis by focusing on the well-known disappearance
of circulating DCs. Beyond the description of the DC ontogeny
and functions, they discuss about novel myelopoiesis-based
therapeutic targeting MPS cells in sepsis. As described above,
sometimes infection may lead to uncontrolled inflammation
causing immunopathology. In their study, Peralta-Ramos et al.
address the role of type-I interferons (IFN-I) in establishing
and developing neuroinflammatory diseases. Upon systemic
inflammatory challenge, they show that IFN-I promotes
the recruitment of inflammatory monocytes into the brain,
which subsequently induces local T cell activation leading
to immunopathology.
MPS BIOLOGY IN DIFFERENT
INFECTIOUS DISEASES
This section addresses the interaction of human and mouse
MPS with different types of pathogens: bacterial, viral, fungal,
and parasitic.
Tuberculosis Disease
Reflecting the expertise contained within our editorial group,
we provide a robust collection of articles that address MPS
cell interaction with Mycobacterium tuberculosis (Mtb), the
etiological agent responsible for tuberculosis. Within the context
of cell heterogeneity, Sampath et al. discuss how monocyte
subsets participate as effector and cell targets contributing to
the control and pathogenesis of Mtb, respectively. Likewise,
Marakalala et al. review macrophage heterogeneity in Mtb
tropism, granuloma formation and maintenance, activation and
product secretion during infection, foam cell formation, and
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caseation, among other aspects. Contrary to classical activation
of pro-inflammatory macrophages with IFNγ, there are other
immune signals that activate macrophages toward alternative
phenotypes, such as interleukin (IL)-4, IL-10, and IL-6. In
their study, Lugo-Villarino et al. address the role of the C-type
lectin receptor (CLR) DC-SIGN, a marker for IL-4-activated
macrophages, in the response against Mtb. While this CLR
helps Mtb to parasitize macrophages, they describe a parallel
role as a molecular switch to turn off the pro-inflammatory
response to prevent unwanted immunopathology associated to
tuberculosis. Using an acellular fraction of tuberculous pleural
effusions as a physiological source of local factors released
during Mtb infection, Genoula et al. characterize how the IL-
10/STAT3 axis induces foam cell differentiation by activating the
enzyme acyl CoA:cholesterol acyl transferase, contributing to our
understanding of how alterations of the host metabolic pathways
may favor pathogen persistence. Excessive activation toward a
macrophage subset may often lead to susceptibility to pathogen
invasion or immunopathological disorders. Employing a mouse
model targeting the deletion of the suppressor of cytokine
signaling 3 (SOCS3) specifically in macrophages, Schmok et
al. demonstrate how SOCS3 prevents macrophage activation
driven by IL-6, increasing susceptibility to Mtb replication in
lung macrophage.
Continuing with the interaction between macrophages and
Mtb, Queval et al. review the molecular events governing the
bacilli survival, and how it is able to transform macrophages
into survival and dissemination vessels. One of these aspects
is the regulation of metabolism that is critical in shaping
macrophage activation and immune functions. Teng et al.
write about mycobacterial lipid-based tactics to manipulate
host metabolism. They address the emerging roles of lipids
in the complex host–pathogen relationship, and discuss recent
methodologies used to assess lipid dynamics during infection
(Teng et al.). Within this context, Oldenburg et al. report how
mycobacterial phenolic glycolipids (PGL) decrease the TLR-4-
dependent signaling cascade, resulting in the low production of
pro-inflammatory signals inmacrophages. The authors show that
PGL-1 targets the posttranscriptional decrease of TIR-domain-
containing adapter-inducing interferon-β (TRIF) protein level,
an important component of the TLR-4 signaling pathway.
Likewise, Chavez-Galán et al. describe how Lipoarabinomannan
affects the T-cell immunoglobulin and mucin domain 3
(TIM3)/galectin (GAL)9 pathway by targeting GAL9 expression.
This is important because the interaction between TIM3 and
GAL9 was shown to promote microbicidal activity against Mtb.
Another strategy used by Mtb is to control the activity of host
lysosomal cathepsins in macrophages. Pires et al. demonstrate
that Mtb upregulates miRNAs such as miR-106b-5p, which binds
to the 3′-untranslated region of the mRNA for cathepsin S, thus
preventing its protein expression and consequently increasing
Mtb survival.
Beyond tuberculosis, we include a study on “nutritional
immunity” in the context of Salmonella enterica serovar
Typhimurium infection. This is a host defense strategy against
infection that relies on the sequestration of essential molecules,
such as iron, to prevent pathogen growth. However, pathogens
evolved counter strategies to deal with nutritional immunity.
In their study, Willemetz et al. demonstrate that Salmonella
modulates macrophage iron homeostasis to favor its access
to high intracellular content of iron by downregulating the
iron exporter ferroportin (FPN). Intriguingly, FPN is repressed
through an iron and hepcidin-independent mechanism,
suggesting the cellular iron is indispensable for the growth of
Salmonella inside the macrophages (Willemetz et al.). It will be
interesting to find out whether this is a general host response
observed with other intracellular pathogens infection, such
as Mtb.
As we move forward in understanding the host and Mtb
interactions, there are various aspects that require further
refinement. For example, Donovan et al. address the role of IFN-
I in tuberculosis. In their review, the authors argue the need to
identify the myeloid source for IFN-I production during Mtb
infection in vivo; characterize the roles for individual members
of the IFN-I family; and define whether blood gene expression
signatures in active tuberculosis are a natural consequence
of Mtb infection in humans or an indication of disease
susceptibility. Another field requiring further elucidation is MPS
immunometabolism. Using novel genetic mouse models to delete
acetyl-CoA carboxylase (ACC) 1 and 2 specifically in DCs,
macrophage or T lymphocytes, Stuve et al. clearly demonstrate
that MPS cells do not require these enzymes for the control of
mycobacteria infection. By contrast, targeted deletion in T cells
results in susceptibility to Mtb. One novel approach to more
deeply investigate how Mtb modulates the host response is to
perform mass spectrometry (MS)-based proteomics on infected
cells. Specifically, Hoffmann et al. summarize the progress
made in determining the protein composition of mycobacteria-
containing vacuoles, which has already shown, for example,
how Mtb prevents the fusion of late endosomes and lysosomal
compartments. The authors argue this approach will promote
the development of novel host-directed therapies, particularly
against the emergent drug-resistant Mtb strains. Likewise, Pahari
et al. propose different strategies in their review to reinforce the
functional aspects of the MPS to achieve better control of Mtb.
They discuss multiple molecules to boost the innate immune
system to enhance the emergent field of immunotherapeutics.
For instance, Zhang et al. show in their study that the herbal
medicine, baicalin, induces autophagy activation in Mtb-infected
macrophages leading to a better control of intracellular Mtb.
At the same time, baicalin also regulates the inflammasome-
dependent activation of IL-1β, suggesting this herbal medicine
also controls unnecessary inflammation derived from infection
(Zhang et al.). An area that requires improvement is the
assessment of biomarkers according to the different states of
disease progression and severity. In their study, Ranaivomanana
et al. provide a biomarker signature that is different between
patients with pulmonary and extrapulmonary tuberculosis, and
they correlate it in human macrophages infected in vitro with
clinical strains representative for each tuberculosis disease type.
Finally, inter-species comparisons are helpful not only to advance
our understanding of the MPS, but also necessary to deal with
infectious diseases aﬄicting in domestic animals. In bovines,
the Mycobacterium avium subspecies paratuberculosis (Map)
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causes a chronic intestinal infection known as paratuberculosis,
which leads to significant economic loss to livestock industries.
One of the problems is that early host-pathogen interactions
in bovines remain poorly understood. In their study, Baquero
and Plattner report that γδ T cells influence differentiation,
maturation, and functional aspects of bovine monocytes during
Map infection. The authors argue that modulation of the γδ
T cells/MPS axis represents a viable vaccination/therapeutic
strategy to generate a strong adaptive immunity to counteract
paratuberculosis in bovines (Baquero and Plattner).
Collectively, this series of articles promote the importance of
MPS in the tuberculosis context, and it highlights its therapeutic
potential yet to be exploited to control this disease.
HIV and Other Viral Diseases
Reflecting another area of expertise within our editorial group,
the following article collection addresses MPS cell interaction
with the human immunodeficiency virus (HIV). We start with
a review article by Rodrigues et al., who provide an in-depth
description of HIV-macrophage interaction during the various
stages of the virus life cycle. This is complemented by another
review article from Merino et al. discussing the contribution of
monocytes and macrophages to the infection and progression
of HIV and SIV, a closely related HIV-like virus that causes
disease similar to AIDS in monkeys and apes. The macrophage
interaction with HIV is important because it influences the
adaptive immune response. Trifone et al. demonstrate the role
of macrophage migration inhibitory factor (MIF)/CD74 axis in
HIV pathogenesis. They show that HIV-1 infection of CD74+
macrophages results in a pro-inflammatory environment in the
presence of MIF, which predisposes unactivated CD4+ T cells to
HIV-1 infection (Trifone et al.).
Another way the MPS participates in HIV pathogenesis is
through cell-to-cell transmission of the virus, including through
interactions with lymphocytes. In their review, Bracq et al.
provide a description of the different mechanisms that occur
during cell-to-cell transmission of HIV, such as intercellular
structures and membrane protrusions, immunological synapses,
efferocytosis of dying cells, and cell-to-cell fusion. Concerning
intercellular structures and membrane protrusions, Dupont et
al. focus their review on tunneling nanotubes (TNT), which
are long membranous dynamic structures and a novel route
for cell-to-cell communication. They argue TNT serve as
major “corridors” for viral to spread efficiently to bystander
cells and remain undetected by the immune system (Dupont
et al.). As a strategy to hijack cell-to-cell communication
between MPS cells, Martinez-Picado et al. write about the
lectin receptor Siglec-1/CD169 that facilitates the binding of
HIV-1 without internalization and, consequently, the infection
of bystander cells. In their review, they discuss how working
with human cohorts lacking Siglec-1 provides a unique
understanding of the role this receptor plays in viral pathogenesis
in vivo.
An important issue of HIV-positive patients is their
susceptibility of co-infection with other pathogens. For example,
patients living with HIV are more likely to die from tuberculosis
than HIV-negative people. Addressing this issue, Gupta-Wright
et al. developed a flow cytometry-based fluorescent reporter of
phagosomal oxidase activity to demonstrate impaired superoxide
burst activity in the phagocytes of hospitalized HIV-positive
patients with tuberculosis. The authors promote the use of
this assay to assess the immune competence of co-infected
patients in clinical settings, including the activation state of
MPS cells. Another complication in HIV-positive patients is
susceptibility to opportunistic pathogens such as non-typhoidal
Salmonella enterica serovar Typhimurium, which is the most
common cause of bacterial bloodstream infections in these
patients. In their review, Lê-Bury and Niedergang describe how
macrophage function is impaired upon HIV infection, discuss
factors that make invasive Salmonella Typhimurium specific for
HIV pathogenesis, and provide reasons for why these bacteria are
well-suited to invade the HIV-infected host.
This section closes with an overall look at the MPS in the
context of other viral infections. Pombo and Sanyal review
different mechanisms of altering lipid metabolic pathways during
infection by flaviviruses, and they focus on cholesterol and fatty
acid biosynthesis. Intriguingly, these events can promote an
advantage for invading viruses to support replication, and thus
they can be modulated for the benefit of the host as a mean
to fight infection. Since the Human Respiratory Syncytial Virus
(hRSV) is responsible for bronchiolitis, pneumonia, recurrent
wheezing and asthma, Bohmwald et al. provide a review on
the role of the lung MPS during hRSV infection and their
involvement in its pathogenesis. This is critical given that hRSV
causes functional impairment of the MPS. Next, Mulder et
al. use the Lymphocytic Choriomeningitis Virus (LCMV), of
the family Arenaviridae, an etiological agent for human acute
aseptic meningitis and grippe-like infections, to understand how
different macrophage subsets are able to control viral infection
and activate the adaptive immune response in the mouse model.
In their study, they show that IL-4-activated macrophages do not
support CD8+ T-cell proliferation and effector functions during
virus infection, as opposed to other macrophages activated by
stimuli such as IFN-γ, for example. As part of the inter-species
comparisons included in this eBook, Zhang et al. assess the
impact of virulent Newcastle Disease Virus (NDV) infection in
the macrophage compartment in chickens. Indeed, NDV causes
Newcastle disease that is highly contagious and fatal in birds
that dramatically affects the global domestic poultry production.
The authors describe that themacrophage compartment becomes
susceptible to viral replication due to inhibition of TLR-7-
dependent signaling, which is avoided by pre-treatment with
TLR-7 ligand (Zhang et al.).
Together, this series of articles promote the importance of
MPS in viral infection, highlighting the need to better understand
the interaction of MPS cells with viruses and the mechanisms
involved in viral subversion and evasion strategies.
Fungal and Parasitic Diseases
This eBook continues with an overall perspective of the
MPS in the context of parasite and fungal infection. Human
parasites are divided into endoparasites (cause infection inside
the body) and ectoparasites (cause infection superficially
within the skin). Parasitic worms (helminths) are endoparasites
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that infect ∼24% of the entire human population. For this
reason, Motran et al. provide a discussion of the recognition
and modulation of the MPS during helminth infections. In
particular, they address excretory-secretory products resulting
from helminth recognition by DCs and macrophages. With
regards to recognition of helminths, van Die and Cummings shed
light on the macrophage Mannose Receptor (MR) in the MPS to
that shapes the immune responses to these parasites, and they
deliver an overview of the structural aspects of this receptor along
with important functional implications. Another endoparasite
that aﬄicts the human population and affects the MPS is African
trypanosomosis, which causes a debilitating disease known as
“sleeping sickness.” In their review, Stijlemans et al. deliver a
discussion of how factors derived from this parasite and the MPS
contribute to trypanosomosis-associated anemia development,
along with intervention strategies partially targeting the MPS to
alleviate this disease. This is complemented by another review by
Holzmuller et al., who focus on how trypanosomatid excreted-
secreted or host molecules affect the metabolic balance between
nitric oxide synthase/arginase in the activation of macrophages,
and their overall impact on the pathogenesis of this disease.
Within the metabolic context, Rojas-Márquez et al. report that
Trypanosoma cruzi, the causative agent for Chagas’ disease, is
controlled inside macrophages by the activation of the NLRP3
inflammasome and reactive oxygen species (ROS) production.
Interestingly, they show that the metabolic checkpoint kinase
mammalian target of rapamycin (mTOR) is activated by T. cruzi
infection and it negatively regulates the NLRP3 activation, and its
pharmacological inhibition restores the microbicidal properties
of macrophages against this parasite (Rojas-Márquez et al.).
Leishmaniasis is a disease caused by protozoa endoparasites
of the Leishmania order, affecting 4–12 million people in
the world. It is manifested at the cutaneous, mucocutaneous
or visceral level. In the context of cutaneous Leishmaniasis
caused by L. major, Vellozo et al. show that, while this
parasite promotes the pro-inflammatory activation of anti-
parasitic macrophages, the all-trans retinoic acid (ATRA) therapy
prevents this differentiation rendering susceptibility in the
host. This is important because the ATRA treatment has been
proposed as a therapy to differentiate immature myeloid cells
into macrophages to boost immunity against tumors, suggesting
an increased risk for endoparasite infections in such patients.
In the context of visceral Leishmaniasis caused by L. infantum,
Peres et al. address the role of Ecto-nucleotidases in the infection
of human macrophages. They demonstrate ecto-nucleotidase
activity of L. infantum is directly associated with infectivity of
macrophages, which is blocked using antibodies targeting this
enzyme, opening new therapeutic avenues against Leishmaniasis
and other trypanosomitides infections (Peres et al.). Other forms
of endoparasite are parasitic flukes, such as liver fluke disease
that is caused by Fasciola hepatica. In their study, Carasi et
al. investigate the role of heme-oxygenase-1 (HO-1) in the
immunoregulation of DCs by F. hepatica. They show that the
HO-1 expression favors this parasite infection, resulting in
increased clinical signs and liver damage. This is associated with
the upregulation of IL-10 that down-modulates the activation
of DCs and macrophages. Indeed, the authors demonstrate that
enzymatic inhibition of HO-1 leads to a decrease of IL-10 and
an increase in the resistance of mice against infection, indicating
that F. hepatica employs HO-1 to subvert the MPS (Carasi et al.).
Finally, ectoparasites can also be a burden to the human
population even in developed countries. For example, tick-
transmitted Anaplasma phagocytophilum is responsible for
human granulocytic anaplasmosis, which is the third most
common human vector-borne infection in USA causing
lethality in 1% of patients. Here, Scorpio et al. report
that impaired cytotoxicity against A. phagocytophilum is
associated with a defect in APCs that express MHC class
I and interact with innate and adaptive immune cells
during infection, inferring that parasite-derived products
may alter the MPS functions to circumvent CD8+ T
cell cytotoxicity.
This section concludes with a brief overview of the role
of MPS in mycosis, which are a public health problem
aﬄicting humans; there is an estimated 1.6 million people who
die each year of fungal infections. To understand the host-
fungi interactions, fundamental research has turned partially
toward the use of fungal cell wall polysaccharides due to
their immunogenicity properties and potential to be therapeutic
compounds in infectious disease. In their review, Camili et
al. write about the complexity of MPS interaction with β-
glucan, the most abundant fungal cell wall polysaccharide.
It is argued that a better understanding of the biochemical
and immunogenicity properties of the different fungal β-
glucans (isolated from different sources) will be necessary
to uncover novel cellular and molecular mechanisms of
action, and to improve a rational use in the future as an
adjuvant or therapeutic agent. One of the problems with blood
stream fungal infection is the lack of an appropriate and
rapid treatment. This is the main issue addressed by Leonor
Fernades-Saraiva et al., who developed a combined classifier
approach with distinct differential gene expression profiles across
multiple studies to generate an exclusive lysosome-related gene
expression as a blood monocyte-specific footprint for fungal
infections. This is crucial because it is specific for fungal (as
opposed to bacterial) infection and it may allow its rapid
identification in the patient’s blood. Within the context of
therapeutic perspectives, Benmoussa et al. identify a novel
compound P17, derived from ant venom, with the capacity
to modulate macrophage differentiation toward an anti-fungal
phenotype characterized by a signaling pathway dependent on
the peroxisome proliferator-activated receptor gamma (PPARγ),
Dectin-1 and MR receptors.
Taken in concert, while the MPS plays a key role in
controlling and generating immunity against parasitic and fungal
infections, these pathogens have also evolved strategies to
circumvent and subvert the MPS. Understanding this complexity
represents an opportunity for diagnostic, prevention, and
therapeutic advances.
ALTERNATIVE AND NOVEL MODELS
In this section, we offer a wider perspective of the MPS with a
series of articles describing alternative animal and cellular models
to highlight different approaches, limitations, and advantages to
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better define MPS functional properties that can be exploited for
therapeutic and vaccination purposes.
With regard to animal models, the zebrafish (Danio rerio)
model symbolizes complementarity with the human and mouse
models. This is a unique platform to study the MPS interaction
with pathogens in vivo, ranging from the single cell level to
the whole organism. Advantages include: non-invasive real-
time visualization of the MPS system, chemical and genetic
tractability, and this model is a natural host of a great number
of pathogens of bacteria, virus, parasite and fungal origin,
among others. In their review, Yoshida et al. argue why
zebrafish are a unique model to study macrophage-microbe
interactions, focusing on recent developments in the context
of bacterial and fungal infection. Furthermore, Boucontet et
al. promote zebrafish as a model of superinfection with a
virus (i.e., Sindbis virus) and a bacterium (i.e., Shigella). In
their study, they uncover a virus-induced hyper-susceptibility to
bacterial infection that is associated with defects in neutrophil
functions. Thus, zebrafish offer an alternative model to better
understand this phenomenon, and a platform for drug-testing
and therapeutic-development to restore the host immunity
(Boucontet et al.).
In terms of cellular models, use of the soil dwelling, social
amoeba Dictyostelium discoideum, is already making important
contributions to our understanding of cell-autonomous
mechanisms in MPS cells. Dunn et al. provide a review of
the advantages and relevance of D. discoideum to study the
antimicrobial functions of phagocytosis and autophagy, and
the microbial properties of the phagosome. Reciprocally,
they also discuss microbial interference with these defenses,
and address a variety of conserved microbial restriction
factors in D. discoideum that are relevant to the mammalian
MPS. Another cellular model likely to make an impact is
that of embryonic derived, self-renewing human tissue-
resident macrophages (Max Planck Institute, MPI cells), which
mimic lung alveolar macrophages. In their study, Woo et al.
perform characterization of the responses of MPI cells to Mtb
infection, including recognition and ingestion of live Mtb,
bacterial intracellular replication, induction of pro- and anti-
inflammatory cytokines, microbicidal activity and elimination
of bacteria, and accumulation of lipid droplets in the cytoplasm
upon lipoprotein exposure. The authors conclude that MPI
cells are a tractable cell model for tuberculosis research that will
enhance our understanding of human alveolar macrophages
(Woo et al.). Finally, Iakobachvili and Peters provide an outlook
on the “Organoid Revolution” that is currently taking place in
all fields of biology. They explain organoid technology, describe
its current impact in infectious diseases, and discuss how it
may be used to study MPS biology in infection (Iakobachvili
and Peters). Altogether, these cellular models are compliant
with the 3Rs (Replace, Reduce, Refine) initiative to reduce
the use of animals to study the MPS, and provide a context
to study cell-autonomous defenses independent of other
immune responses.
SUMMARY
We compiled expertise of scientists of all career stages and from
23 countries and five continents to address recent progress,
highlight critical knowledge gaps, foment scientific exchange, and
establish conceptual frameworks for future MPS investigation
in the context of infectious disease. We hope that the present
MPS conceptual framework will enhance the reader’s knowledge
within the infectious disease context, and inspire new lines of
investigation to further fuel the progress in this field.
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